| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoxia | 11 | 2020 | 63 | 1.490 |
Why?
|
| Dissection | 4 | 2020 | 27 | 1.340 |
Why?
|
| Cartilage, Articular | 14 | 2010 | 549 | 1.310 |
Why?
|
| Cerebral Arteries | 7 | 2017 | 32 | 1.210 |
Why?
|
| Anatomy | 4 | 2020 | 15 | 1.020 |
Why?
|
| Carotid Arteries | 7 | 2021 | 53 | 1.010 |
Why?
|
| Sheep | 17 | 2017 | 42 | 0.990 |
Why?
|
| Ultrasonography, Interventional | 2 | 2016 | 70 | 0.900 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 15 | 0.720 |
Why?
|
| Animals | 36 | 2021 | 4722 | 0.710 |
Why?
|
| Muscle, Smooth, Vascular | 9 | 2017 | 16 | 0.690 |
Why?
|
| Education, Medical | 1 | 2020 | 49 | 0.680 |
Why?
|
| Vasodilation | 6 | 2017 | 19 | 0.640 |
Why?
|
| Chondrocytes | 6 | 2010 | 207 | 0.610 |
Why?
|
| Brachial Plexus Block | 1 | 2016 | 1 | 0.550 |
Why?
|
| Endothelium, Vascular | 3 | 2006 | 65 | 0.550 |
Why?
|
| Anatomic Landmarks | 1 | 2016 | 7 | 0.540 |
Why?
|
| Brachial Plexus | 1 | 2016 | 5 | 0.540 |
Why?
|
| Fetal Hypoxia | 3 | 2017 | 3 | 0.540 |
Why?
|
| Aging | 9 | 2017 | 1727 | 0.520 |
Why?
|
| Myosin-Light-Chain Kinase | 5 | 2021 | 5 | 0.510 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 43 | 0.480 |
Why?
|
| Fetus | 9 | 2021 | 59 | 0.460 |
Why?
|
| Hyaluronic Acid | 3 | 2004 | 102 | 0.460 |
Why?
|
| Proteoglycans | 7 | 2009 | 345 | 0.450 |
Why?
|
| Guanylate Cyclase | 3 | 2011 | 3 | 0.440 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2014 | 81 | 0.430 |
Why?
|
| Thigh | 1 | 2012 | 32 | 0.410 |
Why?
|
| Vasoconstriction | 5 | 2020 | 25 | 0.400 |
Why?
|
| Graft Survival | 2 | 2009 | 98 | 0.390 |
Why?
|
| Nerve Block | 1 | 2012 | 65 | 0.380 |
Why?
|
| Oxygen | 2 | 2012 | 87 | 0.380 |
Why?
|
| Myosin Light Chains | 4 | 2021 | 6 | 0.360 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 4 | 2017 | 5 | 0.340 |
Why?
|
| Menisci, Tibial | 2 | 2008 | 186 | 0.340 |
Why?
|
| Rotator Cuff Injuries | 3 | 2008 | 298 | 0.320 |
Why?
|
| Asepsis | 1 | 2008 | 2 | 0.320 |
Why?
|
| Stress, Mechanical | 3 | 2011 | 173 | 0.310 |
Why?
|
| Cartilage Diseases | 3 | 2006 | 90 | 0.310 |
Why?
|
| Cell Survival | 5 | 2009 | 164 | 0.300 |
Why?
|
| Arachnoid | 1 | 2007 | 11 | 0.290 |
Why?
|
| Surgical Wound Infection | 1 | 2008 | 103 | 0.290 |
Why?
|
| Calcinosis | 1 | 2007 | 50 | 0.280 |
Why?
|
| Vascular Remodeling | 3 | 2017 | 8 | 0.280 |
Why?
|
| Cartilage | 1 | 2008 | 159 | 0.280 |
Why?
|
| Rotator Cuff | 2 | 2006 | 283 | 0.280 |
Why?
|
| Nitric Oxide | 5 | 2011 | 103 | 0.260 |
Why?
|
| Organ Preservation | 1 | 2005 | 6 | 0.250 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 3 | 2014 | 4 | 0.250 |
Why?
|
| Spinal Diseases | 1 | 2007 | 155 | 0.250 |
Why?
|
| Prostheses and Implants | 1 | 2006 | 167 | 0.240 |
Why?
|
| Contractile Proteins | 3 | 2014 | 6 | 0.230 |
Why?
|
| Bone Transplantation | 2 | 2009 | 234 | 0.230 |
Why?
|
| Male | 17 | 2016 | 16442 | 0.230 |
Why?
|
| Pregnancy | 7 | 2020 | 404 | 0.220 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2010 | 225 | 0.220 |
Why?
|
| Muscle Contraction | 5 | 2017 | 83 | 0.220 |
Why?
|
| Protective Agents | 1 | 2003 | 11 | 0.220 |
Why?
|
| Dogs | 7 | 2008 | 263 | 0.210 |
Why?
|
| Educational Measurement | 2 | 2016 | 61 | 0.210 |
Why?
|
| Wound Healing | 2 | 2006 | 174 | 0.210 |
Why?
|
| Female | 17 | 2021 | 16980 | 0.200 |
Why?
|
| Osteogenesis, Distraction | 3 | 2007 | 14 | 0.200 |
Why?
|
| Mandible | 3 | 2007 | 16 | 0.200 |
Why?
|
| Femur | 1 | 2005 | 402 | 0.200 |
Why?
|
| Models, Animal | 5 | 2009 | 130 | 0.200 |
Why?
|
| Brain | 1 | 2011 | 1801 | 0.180 |
Why?
|
| Humans | 17 | 2020 | 30994 | 0.180 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2016 | 32 | 0.180 |
Why?
|
| Carotid Artery, Common | 2 | 2011 | 8 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2011 | 27 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2013 | 442 | 0.170 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 2 | 2017 | 6 | 0.170 |
Why?
|
| Cadaver | 3 | 2016 | 380 | 0.170 |
Why?
|
| Transplantation, Homologous | 4 | 2009 | 295 | 0.170 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 5189 | 0.160 |
Why?
|
| Cattle | 3 | 2009 | 219 | 0.160 |
Why?
|
| Rabbits | 5 | 2008 | 286 | 0.150 |
Why?
|
| Students, Medical | 2 | 2016 | 49 | 0.150 |
Why?
|
| Collagen | 3 | 2009 | 103 | 0.150 |
Why?
|
| Endothelin-1 | 1 | 2017 | 8 | 0.150 |
Why?
|
| Middle Cerebral Artery | 1 | 2017 | 9 | 0.150 |
Why?
|
| Acetabulum | 2 | 2012 | 203 | 0.140 |
Why?
|
| Bupivacaine | 2 | 2008 | 57 | 0.140 |
Why?
|
| Animals, Newborn | 3 | 2007 | 59 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 818 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2017 | 152 | 0.140 |
Why?
|
| Histology | 1 | 2016 | 3 | 0.140 |
Why?
|
| Anesthetics, Local | 2 | 2008 | 97 | 0.140 |
Why?
|
| Psychological Theory | 1 | 2016 | 11 | 0.140 |
Why?
|
| Phosphorylation | 5 | 2021 | 164 | 0.140 |
Why?
|
| Calcium | 3 | 2021 | 502 | 0.130 |
Why?
|
| Mandibular Condyle | 2 | 2006 | 5 | 0.130 |
Why?
|
| Nitric Oxide Synthase | 2 | 2008 | 47 | 0.130 |
Why?
|
| Temporal Bone | 2 | 2006 | 12 | 0.130 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 118 | 0.130 |
Why?
|
| Sympathetic Nervous System | 1 | 2015 | 9 | 0.130 |
Why?
|
| Curriculum | 3 | 2016 | 173 | 0.120 |
Why?
|
| Hypoxia, Brain | 1 | 2015 | 11 | 0.120 |
Why?
|
| Chronic Disease | 5 | 2013 | 532 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2012 | 230 | 0.120 |
Why?
|
| Hindlimb | 3 | 2004 | 25 | 0.120 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 549 | 0.120 |
Why?
|
| Middle Aged | 6 | 2016 | 10192 | 0.120 |
Why?
|
| Soluble Guanylyl Cyclase | 2 | 2011 | 2 | 0.110 |
Why?
|
| Cyclic GMP | 3 | 2013 | 11 | 0.110 |
Why?
|
| Time Factors | 5 | 2016 | 1672 | 0.110 |
Why?
|
| Serotonin | 1 | 2013 | 37 | 0.110 |
Why?
|
| Organ Culture Techniques | 3 | 2020 | 29 | 0.110 |
Why?
|
| Femur Neck | 1 | 2012 | 18 | 0.100 |
Why?
|
| Arteries | 1 | 2012 | 20 | 0.100 |
Why?
|
| Myosin Heavy Chains | 1 | 2012 | 8 | 0.100 |
Why?
|
| Aged | 4 | 2016 | 10045 | 0.100 |
Why?
|
| Femur Head | 1 | 2012 | 67 | 0.100 |
Why?
|
| Compressive Strength | 2 | 2008 | 29 | 0.100 |
Why?
|
| Protein Transport | 3 | 2020 | 40 | 0.100 |
Why?
|
| Disease Models, Animal | 5 | 2009 | 781 | 0.100 |
Why?
|
| Shoulder Joint | 2 | 2008 | 605 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2006 | 817 | 0.100 |
Why?
|
| Sheep, Domestic | 2 | 2021 | 2 | 0.090 |
Why?
|
| Thionucleotides | 2 | 2013 | 6 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 1210 | 0.090 |
Why?
|
| Gestational Age | 2 | 2021 | 78 | 0.090 |
Why?
|
| Peer Group | 1 | 2011 | 42 | 0.090 |
Why?
|
| Homeostasis | 1 | 2011 | 86 | 0.090 |
Why?
|
| Teaching | 1 | 2011 | 62 | 0.090 |
Why?
|
| Gene Expression | 1 | 2011 | 239 | 0.090 |
Why?
|
| Learning | 1 | 2011 | 80 | 0.090 |
Why?
|
| Transplants | 1 | 2009 | 11 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 17 | 0.080 |
Why?
|
| Models, Biological | 2 | 2010 | 346 | 0.080 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2009 | 8 | 0.080 |
Why?
|
| Tissue Adhesives | 1 | 2009 | 8 | 0.080 |
Why?
|
| Tissue Engineering | 1 | 2009 | 39 | 0.080 |
Why?
|
| Age Factors | 3 | 2021 | 873 | 0.080 |
Why?
|
| Biocompatible Materials | 2 | 2006 | 104 | 0.080 |
Why?
|
| Preservation, Biological | 1 | 2008 | 4 | 0.080 |
Why?
|
| Cold Temperature | 1 | 2008 | 18 | 0.080 |
Why?
|
| Shoulder Pain | 1 | 2008 | 61 | 0.080 |
Why?
|
| Freezing | 1 | 2008 | 15 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2008 | 54 | 0.080 |
Why?
|
| Temperature | 1 | 2008 | 74 | 0.080 |
Why?
|
| Hip Joint | 1 | 2012 | 406 | 0.070 |
Why?
|
| Tendinopathy | 1 | 2008 | 61 | 0.070 |
Why?
|
| Biopsy | 1 | 2008 | 249 | 0.070 |
Why?
|
| Cryopreservation | 1 | 2008 | 28 | 0.070 |
Why?
|
| Arachnoiditis | 1 | 2007 | 5 | 0.070 |
Why?
|
| Cell Hypoxia | 2 | 2020 | 14 | 0.070 |
Why?
|
| Humerus | 1 | 2008 | 103 | 0.070 |
Why?
|
| Actin Cytoskeleton | 1 | 2007 | 13 | 0.070 |
Why?
|
| Cell Death | 1 | 2007 | 61 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2012 | 1898 | 0.070 |
Why?
|
| Temporomandibular Joint | 1 | 2007 | 12 | 0.070 |
Why?
|
| Polyurethanes | 1 | 2006 | 9 | 0.070 |
Why?
|
| Polycarboxylate Cement | 1 | 2006 | 8 | 0.070 |
Why?
|
| Keratan Sulfate | 2 | 2004 | 27 | 0.070 |
Why?
|
| Knee Joint | 2 | 2010 | 826 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2006 | 26 | 0.070 |
Why?
|
| Calmodulin | 2 | 2021 | 11 | 0.070 |
Why?
|
| Injections, Intra-Articular | 2 | 2006 | 97 | 0.070 |
Why?
|
| Ultrasonic Therapy | 1 | 2006 | 20 | 0.070 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2006 | 29 | 0.070 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2006 | 5 | 0.070 |
Why?
|
| Tibia | 1 | 2008 | 274 | 0.070 |
Why?
|
| Pregnancy, Animal | 1 | 2006 | 4 | 0.070 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2006 | 18 | 0.070 |
Why?
|
| Materials Testing | 1 | 2006 | 134 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2006 | 113 | 0.060 |
Why?
|
| Hemostasis | 1 | 2005 | 11 | 0.060 |
Why?
|
| Sulfur Radioisotopes | 1 | 2005 | 13 | 0.060 |
Why?
|
| Basilar Artery | 1 | 2005 | 3 | 0.060 |
Why?
|
| Sulfates | 1 | 2005 | 16 | 0.060 |
Why?
|
| Suture Techniques | 1 | 2006 | 144 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 468 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2005 | 16 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2007 | 662 | 0.060 |
Why?
|
| Osteoarthritis, Knee | 1 | 2010 | 400 | 0.060 |
Why?
|
| Ankle Joint | 1 | 2005 | 41 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2006 | 329 | 0.060 |
Why?
|
| Ionophores | 1 | 2004 | 3 | 0.060 |
Why?
|
| Calcimycin | 1 | 2004 | 5 | 0.060 |
Why?
|
| Adenosine Diphosphate | 1 | 2004 | 6 | 0.060 |
Why?
|
| Indomethacin | 1 | 2004 | 8 | 0.060 |
Why?
|
| Calcitonin | 1 | 2004 | 15 | 0.060 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2004 | 40 | 0.060 |
Why?
|
| Rats | 1 | 2006 | 873 | 0.060 |
Why?
|
| Tendon Injuries | 1 | 2006 | 205 | 0.060 |
Why?
|
| Phthalazines | 2 | 2014 | 8 | 0.060 |
Why?
|
| Pyridines | 2 | 2014 | 47 | 0.050 |
Why?
|
| Chymopapain | 1 | 2003 | 5 | 0.050 |
Why?
|
| Viscosity | 1 | 2003 | 10 | 0.050 |
Why?
|
| Fibronectins | 1 | 2003 | 33 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2003 | 98 | 0.050 |
Why?
|
| Radiography | 3 | 2012 | 695 | 0.050 |
Why?
|
| Catalysis | 1 | 2021 | 13 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2021 | 83 | 0.050 |
Why?
|
| Kinetics | 1 | 2021 | 226 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2020 | 5 | 0.050 |
Why?
|
| Altitude | 1 | 2020 | 3 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2020 | 12 | 0.050 |
Why?
|
| Proteolysis | 1 | 2020 | 13 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 17 | 0.050 |
Why?
|
| Osteoarthritis | 1 | 2004 | 383 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 91 | 0.040 |
Why?
|
| Extracellular Matrix | 2 | 2010 | 75 | 0.040 |
Why?
|
| Random Allocation | 2 | 2009 | 146 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 144 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2017 | 40 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 35 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 20 | 0.040 |
Why?
|
| United States | 2 | 2016 | 2375 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2017 | 47 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2005 | 860 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2017 | 215 | 0.040 |
Why?
|
| Schools, Medical | 1 | 2016 | 21 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 2015 | 3 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2015 | 21 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 43 | 0.030 |
Why?
|
| Psychometrics | 1 | 2016 | 270 | 0.030 |
Why?
|
| Bone Density | 2 | 2006 | 152 | 0.030 |
Why?
|
| Educational Status | 1 | 2016 | 312 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 64 | 0.030 |
Why?
|
| Dasatinib | 1 | 2014 | 1 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2014 | 28 | 0.030 |
Why?
|
| Thiazoles | 1 | 2014 | 31 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2016 | 3656 | 0.030 |
Why?
|
| Adult | 3 | 2015 | 8929 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2013 | 2 | 0.030 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2013 | 9 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 11 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2013 | 28 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 32 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2013 | 23 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2013 | 178 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 57 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 7 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 8 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 5 | 0.020 |
Why?
|
| Tunica Media | 1 | 2011 | 15 | 0.020 |
Why?
|
| Actins | 1 | 2011 | 46 | 0.020 |
Why?
|
| Potassium | 1 | 2011 | 68 | 0.020 |
Why?
|
| Group Processes | 1 | 2011 | 9 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 143 | 0.020 |
Why?
|
| Cell Division | 1 | 2010 | 113 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 98 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2009 | 53 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 96 | 0.020 |
Why?
|
| Goats | 1 | 2009 | 10 | 0.020 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2009 | 1 | 0.020 |
Why?
|
| Altitude Sickness | 1 | 2009 | 2 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 2009 | 10 | 0.020 |
Why?
|
| Regeneration | 1 | 2009 | 27 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2009 | 11 | 0.020 |
Why?
|
| Computer-Assisted Instruction | 1 | 2009 | 26 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2009 | 198 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2009 | 170 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 324 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2008 | 1 | 0.020 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Marine Toxins | 1 | 2008 | 2 | 0.020 |
Why?
|
| Oxazoles | 1 | 2008 | 3 | 0.020 |
Why?
|
| Azepines | 1 | 2008 | 6 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2009 | 136 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2008 | 15 | 0.020 |
Why?
|
| Substance P | 1 | 2008 | 18 | 0.020 |
Why?
|
| Axons | 1 | 2008 | 37 | 0.020 |
Why?
|
| Illinois | 1 | 2009 | 267 | 0.020 |
Why?
|
| Rupture | 1 | 2008 | 121 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 3 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2008 | 23 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 26 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 176 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2009 | 685 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 430 | 0.020 |
Why?
|
| Joints | 1 | 2008 | 99 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2009 | 241 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2006 | 68 | 0.020 |
Why?
|
| Tendons | 1 | 2008 | 229 | 0.020 |
Why?
|
| Epinephrine | 1 | 2006 | 37 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2006 | 84 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2005 | 75 | 0.020 |
Why?
|
| Porosity | 1 | 2005 | 68 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2007 | 429 | 0.020 |
Why?
|
| Technology, Radiologic | 1 | 2005 | 2 | 0.020 |
Why?
|
| Chromium Alloys | 1 | 2005 | 48 | 0.020 |
Why?
|
| Talus | 1 | 2005 | 12 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 57 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2005 | 116 | 0.020 |
Why?
|
| Pain | 1 | 2008 | 426 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2004 | 12 | 0.020 |
Why?
|
| Observer Variation | 1 | 2005 | 118 | 0.020 |
Why?
|
| Bone Regeneration | 1 | 2005 | 76 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2004 | 111 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 131 | 0.010 |
Why?
|
| Aggrecans | 1 | 2004 | 157 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 582 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 2006 | 329 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2005 | 507 | 0.010 |
Why?
|
| Pain, Postoperative | 1 | 2006 | 334 | 0.010 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2004 | 281 | 0.010 |
Why?
|
| Adolescent | 1 | 2008 | 2401 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 1133 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 1921 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 2005 | 578 | 0.010 |
Why?
|